Glenmark Pharma reaches settlement agreement with Pfizer for Axitinib tablets

Glenmark Pharma earlier had also received tentative approval by the US Food and Drug Administration (FDA) for their generic Axitinib tablets, 1 mg and 5 mg on 30th November, 2020

Glenmark Pharma has reached a settlement agreement with Pfizer for Axitinib tablets, 1 mg and 5 mg, the generic version of their Inlyta1 tablets, 1 mg and 5 mg, a statement from Glenmark Pharma said.

The company (Glenmark Pharma) earlier had also received tentative approval by the US Food and Drug Administration (FDA) for their generic Axitinib tablets, 1 mg and 5 mg on 30th November, 2020.

 

Axitinib TabletsGlenmark PharmaPfizer
Comments (0)
Add Comment